These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9888161)

  • 1. Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin.
    Helliwell TR; Wilkinson A; Griffiths RD; McClelland P; Palmer TE; Bone JM
    Neuropathol Appl Neurobiol; 1998 Dec; 24(6):507-17. PubMed ID: 9888161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diaphragm muscle fiber weakness and ubiquitin-proteasome activation in critically ill patients.
    Hooijman PE; Beishuizen A; Witt CC; de Waard MC; Girbes AR; Spoelstra-de Man AM; Niessen HW; Manders E; van Hees HW; van den Brom CE; Silderhuis V; Lawlor MW; Labeit S; Stienen GJ; Hartemink KJ; Paul MA; Heunks LM; Ottenheijm CA
    Am J Respir Crit Care Med; 2015 May; 191(10):1126-38. PubMed ID: 25760684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic inclusion body myositis: morphology, regeneration, and cytoskeletal structure of muscle fibres.
    Arnardottir S; Borg K; Ansved T
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):917-20. PubMed ID: 15146016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients.
    Derde S; Hermans G; Derese I; Güiza F; Hedström Y; Wouters PJ; Bruyninckx F; D'Hoore A; Larsson L; Van den Berghe G; Vanhorebeek I
    Crit Care Med; 2012 Jan; 40(1):79-89. PubMed ID: 21926599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular electrical stimulation prevents muscle wasting in critically ill comatose patients.
    Dirks ML; Hansen D; Van Assche A; Dendale P; Van Loon LJ
    Clin Sci (Lond); 2015 Mar; 128(6):357-65. PubMed ID: 25296344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes.
    Vescovo G; Volterrani M; Zennaro R; Sandri M; Ceconi C; Lorusso R; Ferrari R; Ambrosio GB; Dalla Libera L
    Heart; 2000 Oct; 84(4):431-7. PubMed ID: 10995417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary distal myopathy with granulo-filamentous cytoplasmic inclusions containing desmin, dystrophin and vimentin.
    Helliwell TR; Green AR; Green A; Edwards RH
    J Neurol Sci; 1994 Jul; 124(2):174-87. PubMed ID: 7964869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior poliomyelitis: an immunohistochemical study of cytoskeletal proteins and a marker for muscle fibre regeneration in relation to usage of remaining motor units.
    Borg K; Edström L
    Acta Neurol Scand; 1993 Feb; 87(2):128-32. PubMed ID: 7680180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical and biochemical indicators of muscle damage in vitro: the stability of control muscle and the effects of dinitrophenol and calcium ionophore.
    Helliwell TR; Jackson MJ; Phoenix J; MacLennan P; West-Jordan J; Edwards RH
    Int J Exp Pathol; 1994 Oct; 75(5):329-43. PubMed ID: 7999634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans.
    Di Somma S; Marotta M; Salvatore G; Cudemo G; Cuda G; De Vivo F; Di Benedetto MP; Ciaramella F; Caputo G; de Divitiis O
    Heart; 2000 Dec; 84(6):659-67. PubMed ID: 11083750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the intermediate filament protein synemin in myofibrillar myopathies and other muscle diseases.
    Olivé M; Goldfarb L; Dagvadorj A; Sambuughin N; Paulin D; Li Z; Goudeau B; Vicart P; Ferrer I
    Acta Neuropathol; 2003 Jul; 106(1):1-7. PubMed ID: 12669240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute quadriplegic myopathy with myosin-deficient muscle fibres after liver transplantation: defining the clinical picture and delimiting the risk factors.
    Miró O; Salmerón JM; Masanés F; Alonso JR; Graus F; Mas A; Grau JM
    Transplantation; 1999 Apr; 67(8):1144-51. PubMed ID: 10232565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial desminopathy: myopathy with accumulation of desmin-type intermediate filaments.
    Vajsar J; Becker LE; Freedom RM; Murphy EG
    J Neurol Neurosurg Psychiatry; 1993 Jun; 56(6):644-8. PubMed ID: 8509778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of Yes-associated protein (Yap) in adult skeletal muscle fibres induces muscle atrophy and myopathy.
    Judson RN; Gray SR; Walker C; Carroll AM; Itzstein C; Lionikas A; Zammit PS; De Bari C; Wackerhage H
    PLoS One; 2013; 8(3):e59622. PubMed ID: 23544078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-related protein surplus myopathies.
    Goebel HH; Warlo I
    Mol Genet Metab; 2000; 71(1-2):267-75. PubMed ID: 11001821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophy of non-locomotor muscle in patients with end-stage renal failure.
    Sakkas GK; Ball D; Mercer TH; Sargeant AJ; Tolfrey K; Naish PF
    Nephrol Dial Transplant; 2003 Oct; 18(10):2074-81. PubMed ID: 13679483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ultrastructural and contractile activation properties of crustacean (Cherax destructor) muscle fibres during claw regeneration and moulting.
    West JM; Humphris DC; Stephenson DG
    J Muscle Res Cell Motil; 1995 Jun; 16(3):267-84. PubMed ID: 7560000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human skeletal muscle fibre contractile properties and proteomic profile: adaptations to 3 weeks of unilateral lower limb suspension and active recovery.
    Brocca L; Longa E; Cannavino J; Seynnes O; de Vito G; McPhee J; Narici M; Pellegrino MA; Bottinelli R
    J Physiol; 2015 Dec; 593(24):5361-85. PubMed ID: 26369674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.
    Larsson L; Li X; Edström L; Eriksson LI; Zackrisson H; Argentini C; Schiaffino S
    Crit Care Med; 2000 Jan; 28(1):34-45. PubMed ID: 10667496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human oro-facial and masticatory muscles with respect to fibre types, myosins and capillaries. Morphological, enzyme-histochemical, immuno-histochemical and biochemical investigations.
    Stål P
    Swed Dent J Suppl; 1994; 98():1-55. PubMed ID: 7801228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.